Abstract
The development of genetically engineered subunit vaccines has renewed and intensified efforts to immunize third world populations against currently uncontrolled diseases including malaria; however, the success of such vaccines will depend in large part upon efforts to enhance their immunogenicity. It is likely that subunit vaccines will require potent adjuvants in order to be effective. While considerable work has been aimed at enhancing antibody responses to peptide antigens, little is know regarding the potentiation of antigen specific cell-mediated immune responses. We have utilized a delayed type hypersensitivity (DTH) model to investigate cell-mediated immune responses, including those parameters which affect the induction, magnitude and duration of responsiveness. We examined the potency of R32tet32, a subunit vaccine directed against the sporozoite stage of Plasmodium falciparum, to induce and elicit DTH responses in mice and found that these responses were potentiated significantly through the use of selected lymphokines and immunomodulators.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Del Guidici, G., Cooper, J. A., Merino, J., Verdini, A. S., Pessi, A., Togna, A. R., Engers, H. D., Corradin, G. and Lambert, P. H. 1986. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-A restricted: possible implications for malaria vaccines. J. Immunol. 137:2952.
Gillis, S., Scheid, M., Watson, J. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of interleukin 2-producing T-cell lymphomas. J. Immunol. 125:2570.
Good, M. F., Berzofsky, J. A., Maloy, W. L., Hayashi, Y., Fulii, N., Hockmeyer, W. T., Miller, L. H. 1986. Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to a single malaria T epitope in highly repetitive vaccine. J. Exp. Med. 164:655.
Togna, A. R., Del Giudici, G., Verdini, A. S., Bonelli, F., Pessi, A., Engers, H. D., & Corradin, G. 1986. Synthetic P. falciparum circumsporozoite peptides elicit heterogenous L3T4+Tcell proliferative responses in H-2b mice. J. Immunol. 137:2956.
Young, F. F., Hockmeyer, W. T., Gross, M., Ballou, W. R., Schneider, I., Hollingdale, M. R., Beaudoin, R. L., Hollingdale, M. R., Miller L. H., Diggs, C. L., Rosenberg, M. 1985. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science. 228:958.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Russo, D.M., Sundy, J.S., Maguire, H.C., Weidanz, W.P. (1989). Potentiation of Cell-Mediated Immune Responses Directed against P. Falciparum Sporozoite Peptide Vaccine by Immunomodulators. In: Atassi, M.Z. (eds) Immunobiology of Proteins and Peptides V. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2046-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2046-4_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-2048-8
Online ISBN: 978-1-4757-2046-4
eBook Packages: Springer Book Archive